Skip to main content
Skip to main content
CME logo

CME Group Inc. (CME) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$286.45 +$0.95 (+0.33%) |Exceptional · 88
CME Group Inc. (CME) bottom line: Bullish Lean — our Council read (74/100) and AI Score (88/100) broadly agree. Strongest signal: Business Quality · Biggest watch-out: Financial Safety.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $103B| P/E Ratio: 24.17| Vol: 1.63M| Target: $299.00 (+4.4%) (Sep 2, 2026) (estimate, not advice)| 52-wk range: $218.31 – $329.16

P/E 24.17 means the share price is 24.17 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $103B is the value of all shares combined. Beta 0.30: the stock has moved about 70% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 8, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

CME Group Inc. (CME) trades at $286.45 with AI Score 88/100 (Grade A+). Market cap: $103B, Sector: Financial services.

Price as of Sep 2, 2026 · Last analyzed: May 8, 2026
CME Group Inc. operates as a global derivatives marketplace, providing a wide range of futures and options products across various asset classes. The company also offers clearing and settlement services, playing a crucial role in the global financial infrastructure.

CME stock analysis for 2026: Analysts have set a consensus price target of $299.00 for CME Group Inc., suggesting 4.4% upside from the current price of $286.45. The AI MoonshotScore is 88/100, in the Exceptional band (80-100) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the CME film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 74/100 · A

CME: 3/3 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 88/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Neutral Could this blow up on me?
Valuation
Moderate Am I paying a fair price?
Growth Durability
Moderate Is the growth real and likely to last?
Momentum
Neutral Is the market already moving on this?

Strongest side: Business Quality (10/10, Strong). Weakest side: Financial Safety (5/10, Neutral).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Neutral read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Neutral read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Favorable read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Moderate
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

CME Group Inc. (CME) Financial Services Profile

CEOTerrence A. Duffy
Employees3,875
HeadquartersChicago, IL, US
IPO Year2002

CME Group Inc. operates the world's leading derivatives marketplace, offering futures and options contracts across major asset classes. With a robust clearing and settlement infrastructure, CME Group facilitates risk management and price discovery for a global clientele, maintaining a strong market position within the financial data and stock exchange sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 8, 2026

What Is the Investment Thesis for CME?

As of May 8, 2026 — figures reflect the data available on that date.

With a market capitalization of $103B and a robust profit margin of 62.8%, the company demonstrates financial strength. The company's dividend yield of 3.90% offers an attractive return for investors. Growth catalysts include increasing global demand for risk management tools and the expansion of its product suite into new asset classes. However, potential risks include regulatory changes and increased competition from alternative trading platforms. CME Group's beta of 0.30 indicates lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

CME Key Highlights

Market capitalization of $103B, reflecting its dominant position in the derivatives marketplace.

  • Profit margin of 62.8%, showcasing operational efficiency and pricing power.
  • Gross margin of 86.3%, indicating strong cost control and revenue generation capabilities.
  • Free cash flow of $3.10 billion, providing financial flexibility for strategic investments and shareholder returns.
  • Dividend yield of 3.90%, offering an attractive income stream for investors.

Who Are CME's Competitors?

CME is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BMO Bank of Montreal $168.30 -1.18% $118B 815-pillar
MFG Mizuho Financial Group, Inc. $10.74 +0.94% $131B 605-pillar
IBN ICICI Bank Limited $30.19 -0.56% $108B 415-pillar
BNS The Bank of Nova Scotia $91.19 -0.51% $111B 865-pillar
MMC Marsh & McLennan Companies, Inc. $182.70 -1.58% $89.8B
ICE Intercontinental Exchange, Inc. $159.60 -0.68% $89.6B 775-pillar
MCO Moody's Corporation $494.89 -1.93% $85.7B 875-pillar
SPGI S&P Global Inc. $440.21 +1.00% $130B 785-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CME's Key Strengths?

Dominant market position in the derivatives marketplace.

  • Diversified product offerings across multiple asset classes.
  • Robust clearing and settlement infrastructure.
  • Strong brand reputation and customer loyalty.

What Are CME's Weaknesses?

Dependence on market volatility and trading volumes.

  • Exposure to regulatory changes and compliance costs.
  • Potential for technological disruptions from alternative trading platforms.
  • Vulnerability to cyberattacks and data breaches.

What Could Drive CME Stock Higher?

Increasing global demand for risk management tools due to economic uncertainty.

  • Potential regulatory changes that could benefit CME Group's market position.
  • Expansion of product offerings into new asset classes, such as cryptocurrencies.
  • Technological advancements that enhance trading efficiency and market surveillance.

What Are the Key Risks for CME?

Financial-distress signal — its Altman Z-Score of 0.55 sits in the distress zone (elevated bankruptcy risk).

  • Rich valuation — a P/E of 24.17 runs well above the Financial Services sector’s ~17.50x, leaving little room for a miss.
  • Insider selling — insiders were net sellers of roughly $9.0M recently.
  • Increased competition from alternative trading platforms and exchanges.
  • Regulatory changes that could impact trading volumes and profitability.
  • Economic downturns that could reduce trading activity.
  • Geopolitical risks that could disrupt global markets.
  • Cyberattacks and data breaches that could compromise sensitive information.

What Are the Growth Opportunities for CME?

  • Expansion into new asset classes: CME Group can capitalize on the growing demand for derivatives products in emerging markets and alternative asset classes, such as cryptocurrencies and environmental products. By introducing new futures and options contracts, CME Group can attract new customers and increase trading volumes. The market for cryptocurrency derivatives, for example, is projected to reach $50 billion by 2028, offering a significant growth opportunity.
  • Technological innovation: Investing in advanced trading technologies and data analytics can enhance CME Group's competitive advantage and attract sophisticated traders. By leveraging artificial intelligence and machine learning, CME Group can improve market surveillance, risk management, and trading efficiency. The global market for AI in financial services is expected to reach $26.5 billion by 2027, indicating the potential for significant investment in this area.
  • Strategic acquisitions: CME Group can pursue strategic acquisitions to expand its product offerings, geographic reach, and customer base. By acquiring complementary businesses, such as data providers or technology companies, CME Group can enhance its value proposition and strengthen its market position.
  • Increased demand for risk management tools: As global economic uncertainty increases, the demand for risk management tools, such as futures and options contracts, is expected to rise. CME Group is well-positioned to benefit from this trend, as its products provide a means for hedging against market volatility and managing financial risk. The global market for risk management solutions is projected to reach $35 billion by 2026, indicating the potential for increased demand for CME Group's products.
  • Growth in emerging markets: Emerging markets offer significant growth opportunities for CME Group, as these economies are experiencing rapid growth and increasing demand for financial services. By expanding its presence in these markets, CME Group can tap into new customer segments and increase trading volumes. The emerging markets derivatives market is projected to grow at a rate of 8% per year, offering a significant growth opportunity for CME Group.

What Are CME's Competitive Advantages?

  • Network effect: The more participants trade on CME Group's platform, the more valuable it becomes for all users.
  • High switching costs: Traders and institutions rely on CME Group's infrastructure and clearing services, making it difficult to switch to alternative platforms.
  • Regulatory approvals: CME Group operates under strict regulatory oversight, creating barriers to entry for new competitors.
  • Brand reputation: CME Group has a long-standing reputation for reliability and integrity, attracting a loyal customer base.

What Does CME Do?

Founded in 1898 as the Chicago Butter and Egg Board, CME Group Inc. has evolved into the world's leading derivatives marketplace. Initially focused on agricultural commodities, the company expanded its offerings to include financial instruments, such as interest rates, equity indexes, foreign exchange, energy, and metals. This diversification transformed CME Group into a global financial powerhouse. CME Group provides a platform for trading futures and options on futures contracts, serving a diverse clientele, including professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company's clearing house services ensure the integrity of the market by clearing, settling, and guaranteeing transactions. CME Group also offers market data services, providing real-time and historical data to market participants. Headquartered in Chicago, Illinois, CME Group's global reach and comprehensive product suite solidify its position as a critical component of the global financial infrastructure.

What Products and Services Does CME Offer?

  • Operates contract markets for trading futures and options on futures contracts.
  • Offers products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals.
  • Provides clearing house services, including clearing, settling, and guaranteeing contracts.
  • Offers trade processing and risk mitigation services.
  • Provides real-time and historical market data services.
  • Serves professional traders, financial institutions, and institutional investors.

How Does CME Make Money?

  • Generates revenue from trading fees on futures and options contracts.
  • Earns income from clearing and settlement services.
  • Collects fees for market data services.
  • Benefits from increased trading volumes and market volatility.

What Industry Does CME Operate In?

CME Group operates within the financial data and stock exchange industry, which is characterized by increasing globalization, technological advancements, and regulatory scrutiny. The industry is driven by the need for efficient price discovery, risk management, and access to capital markets. CME Group competes with other exchanges and trading platforms, including Bank of Montreal (BMO), Mizuho Financial Group, Inc. (MFG), ICICI Bank Limited (IBN), The Bank of Nova Scotia (BNS), and Marsh & McLennan Companies, Inc. (MMC). The industry is subject to regulatory oversight, including capital requirements and compliance standards.

Who Are CME's Key Customers?

  • Professional traders
  • Financial institutions
  • Institutional investors
  • Corporations
  • Manufacturers
  • Governments
  • Central banks
Model self-rating on this text: 83% (not a measure of the evidence) Updated: May 8, 2026

Research confidence

High 100/100

Broad, current evidence sits behind this analysis.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 40 days ago
  • Covered by analysts

Why 88?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.78 Net margin (Business Quality)
  • +0.73 Operating margin (Business Quality)
  • +0.67 Return on invested capital (Business Quality)

What is holding it back

  • -0.29 Price to book (Valuation)
  • -0.20 6-month price trend (Momentum)
  • -0.13 5-year revenue per share (Growth)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 10 snapshots

2026-08-23 71
2026-08-25 69
2026-08-27 75
2026-08-29 77
2026-08-31 83
2026-09-01 87

What changed?

The grade moved from 71 to 87 (+16).

What moved it up or down:

  • +30 Momentum
  • +24 Financial Strength
  • +3 Valuation

Held back by:

  • -12 Growth
  • -1 Business Quality

Over the same 9 days the stock moved +3.8%.

CME Group Inc. Financial Trajectory

CME Group Inc. (CME) reported $1.71B in revenue for Q2 FY2026, a decline of 9.2% compared to the prior quarter. The company recorded net income of $1.04B, with diluted EPS of $2.88. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Financial Services. Across the four most recent quarters, CME averaged $2.95 in diluted EPS.

Company Profile

CME Group Inc. operates in the Financial - Data & Stock Exchanges industry within the Financial Services sector. It is headquartered in Chicago, US. The company is led by CEO Terrence A. Duffy. CME has traded publicly since 2002.

How CME Group Inc. Is Valued

CME Group Inc. carries a market capitalization of $103B, placing it in the large-cap category. Analyst price targets span from $260.00 to $330.00, with a consensus of $299.00. At the current price of $286.45, that implies approximately 4% upside potential. Relative to its peer group, CME's quantitative score of 88/100 is above the peer average of 73/100.

ROE 16%

Key Financial Metrics

Return on equity for CME Group Inc. stands at 15.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.6%, showing how much profit it generates from its asset base. CME trades at a trailing price-to-earnings ratio of 24.17, above the Financial Services sector average of ~17.50x. A current ratio of 1.02 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 4/9

Financial Health

CME Group Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.55 places it in the distress zone, a signal of elevated financial risk.

4/8 beats

Earnings Track Record

CME Group Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 1.4% above estimates on average.

Net selling

Insider Activity

Over the past six months, CME Group Inc. insiders filed 30 SEC Form 4 transactions — 4 sales and 26 purchases. On net that is roughly 27K shares disposed (about $9.0M), a signal worth weighing alongside the fundamentals.

CME Financials

Next earnings report:

Fundamental Snapshot

Revenue Growth (FY)
+6.4%
Net Income Growth (FY)
+14.7%
EPS Growth (FY)
+15.4%
Free Cash Flow Growth (FY)
+16.6%
P/E (TTM)
24.17
Return on Equity (TTM)
+15.9%
Current Ratio
1.0

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Dominant market position in the derivatives marketplace.
  • Diversified product offerings across multiple asset classes.
  • Robust clearing and settlement infrastructure.
  • Strong brand reputation and customer loyalty.

Bear Case

  • Dependence on market volatility and trading volumes.
  • Exposure to regulatory changes and compliance costs.
  • Potential for technological disruptions from alternative trading platforms.
  • Vulnerability to cyberattacks and data breaches.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $1.71B $1.04B $2.88
Q1 FY2026 $1.88B $1.15B $3.18
Q4 FY2025 $1.65B $1.17B $3.24
Q3 FY2025 $1.54B $908M $2.49

Q2 FY2026 · filed 24 Jul 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

CME Latest News

CME Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CME.

Price Targets

Low
$260.00
Consensus
$299.00
High
$330.00

Median: $305.50 (+4.4% from current price)

Source: FMP analyst consensus · as of Sep 2, 2026 · an estimate, not advice

CME MoonshotScore

88/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. CME scores 88/100 (Grade A+): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Latest CME Group Inc. Analysis

Leadership: Terrence A. Duffy

Chairman and Chief Executive Officer

Terrence A. Duffy has served as the Chairman and Chief Executive Officer of CME Group since 2012. He began his career at CME in 1981 as a member and has held various leadership positions within the company. Duffy has been instrumental in guiding CME Group through periods of significant growth and transformation. He is actively involved in industry and community organizations, demonstrating his commitment to the financial markets and the Chicago area. Duffy's extensive experience and leadership have been critical to CME Group's success.

Track Record: Under Terrence Duffy's leadership, CME Group has achieved significant milestones, including the integration of the Chicago Board of Trade and the New York Mercantile Exchange. He has overseen the expansion of CME Group's product offerings and its global reach. Duffy has also been a strong advocate for innovation and technological advancements, positioning CME Group as a leader in the financial technology space. His strategic decisions have contributed to the company's strong financial performance and market leadership.

CME Group Inc. Financial Services Stock: Key Questions Answered

What does the AI Score mean for CME?

CME holds an AI Score of 88/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

What does CME Group Inc. do?

CME Group Inc. operates as a global derivatives marketplace, providing a platform for trading futures and options on futures contracts.

What do analysts say about CME stock?

Analyst consensus on CME Group Inc. is generally positive, reflecting the company's strong market position and financial performance. Key valuation metrics, such as the price-to-earnings ratio of 24.17, suggest that the stock is fairly valued compared to its peers.

How does CME Group Inc. make money in financial services?

CME Group Inc. generates revenue primarily through transaction fees charged on futures and options contracts traded on its exchanges. The company also earns income from clearing and settlement services, as well as fees for providing market data to subscribers.

What are the key factors to evaluate for CME?

CME Group Inc. (CME) holds an AI score of 88/100 (high). P/E: 24.17x vs the S&P 500's ~20-25x. Analysts target $299.00 (+4%). Not financial advice.

How frequently does CME data refresh on this page?

CME's price was last updated on Sep 2, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven CME's recent stock price performance?

CME Group Inc. (CME) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Dominant market position in the derivatives marketplace. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CME overvalued or undervalued right now?

CME Group Inc. (CME) trades at 24.17x earnings. Analysts target $299.00 (+4%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of CME?

Yes, most major brokerages offer fractional shares of CME Group Inc. (CME) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • Financial data is as of the latest available reporting period.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover